Annual Current Liabilities
$6.85 M
+$425.40 K+6.63%
December 31, 2021
Summary
- As of February 10, 2025, OPNT annual total current liabilities is $6.85 million, with the most recent change of +$425.40 thousand (+6.63%) on December 31, 2021.
- During the last 3 years, OPNT annual current liabilities has fallen by -$2.98 million (-30.34%).
Performance
OPNT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$7.04 M
+$2.05 M+40.96%
September 30, 2022
Summary
- As of February 10, 2025, OPNT quarterly total current liabilities is $7.04 million, with the most recent change of +$2.05 million (+40.96%) on September 30, 2022.
- Over the past year, OPNT quarterly current liabilities has dropped by -$311.90 thousand (-4.24%).
Performance
OPNT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
OPNT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.6% | -4.2% |
| 3 y3 years | -30.3% | -25.1% |
| 5 y5 years | +21.0% | +61.9% |
OPNT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -29.1% |
| 5 y | 5-year | at high | -18.1% | -4.2% | -38.6% |
| alltime | all time | -30.3% | -100.0% | -28.4% | -100.0% |
Opiant Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.04 M(+41.0%) |
| Jun 2022 | - | $4.99 M(-26.4%) |
| Mar 2022 | - | $6.79 M(-0.8%) |
| Dec 2021 | $6.85 M(+6.6%) | $6.85 M(-6.9%) |
| Sep 2021 | - | $7.35 M(+27.1%) |
| Jun 2021 | - | $5.78 M(-5.9%) |
| Mar 2021 | - | $6.15 M(-4.2%) |
| Dec 2020 | $6.42 M(+14.4%) | $6.42 M(-4.2%) |
| Sep 2020 | - | $6.70 M(+31.2%) |
| Jun 2020 | - | $5.11 M(+18.0%) |
| Mar 2020 | - | $4.33 M(-22.9%) |
| Dec 2019 | $5.61 M(-42.9%) | $5.61 M(-40.3%) |
| Sep 2019 | - | $9.40 M(+7.3%) |
| Jun 2019 | - | $8.76 M(-7.5%) |
| Mar 2019 | - | $9.47 M(-3.6%) |
| Dec 2018 | $9.83 M(+73.7%) | $9.83 M(+163.7%) |
| Sep 2018 | - | $3.73 M(-14.0%) |
| Jun 2018 | - | $4.33 M(-23.4%) |
| Mar 2018 | - | $5.66 M(+30.1%) |
| Dec 2017 | $5.66 M(+35.8%) | - |
| Oct 2017 | - | $4.35 M(+4.4%) |
| Jul 2017 | $4.17 M(-1.6%) | $4.17 M(+33.2%) |
| Apr 2017 | - | $3.13 M(-39.8%) |
| Jan 2017 | - | $5.20 M(+9.3%) |
| Oct 2016 | - | $4.75 M(+12.2%) |
| Jul 2016 | $4.24 M(+18.5%) | $4.24 M(+3.7%) |
| Apr 2016 | - | $4.09 M(+4.8%) |
| Jan 2016 | - | $3.90 M(+2.8%) |
| Oct 2015 | - | $3.79 M(+6.1%) |
| Jul 2015 | $3.57 M | $3.57 M(+45.1%) |
| Apr 2015 | - | $2.46 M(+7.1%) |
| Jan 2015 | - | $2.30 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2014 | - | $2.06 M(+4.7%) |
| Jul 2014 | $1.97 M(+122.8%) | $1.97 M(+31.1%) |
| Apr 2014 | - | $1.50 M(+31.0%) |
| Jan 2014 | - | $1.15 M(-21.0%) |
| Oct 2013 | - | $1.45 M(+64.3%) |
| Jul 2013 | $883.10 K(+33.1%) | $883.10 K(-12.2%) |
| Apr 2013 | - | $1.01 M(+7.0%) |
| Jan 2013 | - | $940.10 K(+8.6%) |
| Oct 2012 | - | $865.50 K(+30.4%) |
| Jul 2012 | $663.70 K(+59.5%) | $663.70 K(+24.3%) |
| Apr 2012 | - | $533.80 K(+45.0%) |
| Jan 2012 | - | $368.10 K(+36.5%) |
| Oct 2011 | - | $269.70 K(-35.2%) |
| Jul 2011 | $416.20 K(+49.3%) | $416.20 K(-7.2%) |
| Apr 2011 | - | $448.30 K(-31.3%) |
| Jan 2011 | - | $652.90 K(-27.4%) |
| Oct 2010 | - | $898.90 K(+222.4%) |
| Jul 2010 | $278.80 K(>+9900.0%) | $278.80 K(-41.3%) |
| Apr 2010 | - | $475.00 K(+84.0%) |
| Jan 2010 | - | $258.20 K(+238.4%) |
| Oct 2009 | - | $76.30 K(>+9900.0%) |
| Jul 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Apr 2009 | - | $41.20 K(+11.7%) |
| Jan 2009 | - | $36.90 K(+10.1%) |
| Oct 2008 | - | $33.50 K(+18.0%) |
| Jul 2008 | $28.40 K(+170.5%) | $28.40 K(+76.4%) |
| Apr 2008 | - | $16.10 K(+10.3%) |
| Jan 2008 | - | $14.60 K(+32.7%) |
| Oct 2007 | - | $11.00 K(+4.8%) |
| Jul 2007 | $10.50 K | $10.50 K(+400.0%) |
| Apr 2007 | - | $2100.00(>+9900.0%) |
| Jan 2007 | - | $0.00 |
FAQ
- What is Opiant Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual current liabilities year-on-year change?
- What is Opiant Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly current liabilities year-on-year change?
What is Opiant Pharmaceuticals annual total current liabilities?
The current annual current liabilities of OPNT is $6.85 M
What is the all time high annual current liabilities for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual total current liabilities is $9.83 M
What is Opiant Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, OPNT annual total current liabilities has changed by +$425.40 K (+6.63%)
What is Opiant Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of OPNT is $7.04 M
What is the all time high quarterly current liabilities for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly total current liabilities is $9.83 M
What is Opiant Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, OPNT quarterly total current liabilities has changed by -$311.90 K (-4.24%)